Loading…
Based on limited metadata, Soulaire Corporation received an FDA Warning Letter on January 29, 2024, regarding medical devices. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA device regulation, though the specific issuing office and violation count are not documented in this metadata summary. For complete details on the regulatory concerns and required corrective actions, the full Warning Letter text would need to be reviewed.